WHO WE ARE
Kidney Care Partners (KCP) was founded in May of 2003 as a coalition of patient advocates, dialysis professionals, care providers, researchers, and manufacturers dedicated to working together to improve quality of care for individuals living with kidney diseases.
KIDNEY CARE FIRST
A Framework for Improving Renal Disease Support & Treatments
Kidney Care FIRST is a broad look at how we can dramatically improve kidney care nationwide, save lives, and achieve potentially billions of dollars in savings to our healthcare system.
More than 88K Americans are currently waiting for a kidney transplant.
Nearly 500K Americans are currently on dialysis.
More than 700K Americans are living with kidney failure (ESRD).
More than 124K Americans are diagnosed with kidney failure each year.
More than 30M Americans are living with chronic kidney disease.
As vaccines roll out, the threat of COVID-19 continues to loom large over those with kidney disease, especially for the millions of Americans living with chronic kidney disease (CKD), end-stage renal disease (ESRD), and kidney transplants. The COVID-19 pandemic has forced all of us in the medical community to confront a disease where we have…
A statement from John P. Butler, chair of Kidney Care Partners (KCP) and president & CEO of Akebia Therapeutics, regarding the coronavirus relief package: “Kidney Care Partners commends bipartisan members of Congress for recognizing the critical need to ensure that individuals living with kidney transplants can continue to access life-saving medications indefinitely to preserve their…
Kidney Community to Administration, Congress: Make Sure Vulnerable Patients Are Among the First in Line for COVID-19 Vaccine
CDC and Public Health Experts State that Patients with Kidney Disease Have Increased Risk of Severe COVID-19 Disease WASHINGTON, DC (November 25, 2020) – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers and manufacturers – today urged the Trump Administration…